We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ONCO:NASDAQOnconetix, Inc. analysis

Data as of Oct 19, 2026 - not real-time

Latest price
$0.42
Risk: high
9/10High risk

Summary

The moving-average structure behind Onconetix, Inc. is bearish at $0.4238, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 58.5%. With RSI at 31.9 the momentum picture is approaching oversold, alongside a bearish MACD signal. Watch $0.4221 as support and $1.42 as the nearer resistance level.
The shares look undervalued, trading on 0.0 times earnings below a sector average of 31.4. Revenue is contracting at 83.9%.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 166.3%, a beta of 0.95 and a maximum drawdown of 99.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 89 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top market events

  • SRX has added ONCO in anticipation of Realbotix LLC acquisition closing.
  • Initial Advance of $2.5 Million to Realbotix LLC to Support Growth and Working Capital; Non-Interest Bearing Facility...
  • Initial Advance of $2.5 Million to Realbotix LLC to Support Growth and Working Capital; Non-Interest Bearing Facility...

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 17.61
  • MACD momentum is negative

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 0.0 versus sector average of 31.4
  • Trading below the 200-day average of 17.61

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • P/E of 0.0 versus sector average of 31.4
  • Negative return on equity of -105.2%
  • Revenue contracting at -83.9%

Key metrics

Financial health

Revenue Growth-83.90%
P/E Ratio0.0
ROE-105.23%
ROA-27.03%
Debt/Equity1.39
P/B Ratio0.1
Op. Cash Flow$-10307962
Free Cash Flow$-5920061
Industry P/E31.4

Technical analysis

TrendBearish
RSI31.9
Support$0.42
Resistance$1.42
MA 20$0.70
MA 50$0.72
MA 200$17.61
MACDBearish
VolumeDecreasing
Fear & Greed Index88.79

Valuation

GradeUndervalued
TypeValue

Risk assessment

Beta0.95
Volatility166.30%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.